These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3355566)

  • 1. Aspirin prevents the nonenzymatic glycosylation and carbamylation of the human eye lens crystallins in vitro.
    Rao GN; Cotlier E
    Biochem Biophys Res Commun; 1988 Mar; 151(3):991-6. PubMed ID: 3355566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylation of lens crystallins: a possible mechanism by which aspirin could prevent cataract formation.
    Rao GN; Lardis MP; Cotlier E
    Biochem Biophys Res Commun; 1985 May; 128(3):1125-32. PubMed ID: 4004853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reaction of aspirin with cysteinyl residues of lens gamma-crystallins: a mechanism for the proposed anti-cataract effect of aspirin.
    Qin W; Smith JB; Smith DL
    Biochim Biophys Acta; 1993 Apr; 1181(2):103-10. PubMed ID: 8481398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycation of human lens crystallins: effect of age and aspirin treatment.
    Cherian M; Abraham EC
    Ophthalmic Res; 1993; 25(6):349-54. PubMed ID: 8309673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin prevents carbamylation of soluble lens proteins and prevents cyanate-induced phase separation opacities in vitro: a possible mechanism by which aspirin could prevent cataract.
    Crompton M; Rixon KC; Harding JJ
    Exp Eye Res; 1985 Feb; 40(2):297-311. PubMed ID: 3979467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro glycation and acetylation (by aspirin) of rat crystallins.
    Cherian M; Abraham EC
    Life Sci; 1993; 52(21):1699-707. PubMed ID: 8502115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ibuprofen, a putative anti-cataract drug, protects the lens against cyanate and galactose.
    Roberts KA; Harding JJ
    Exp Eye Res; 1990 Feb; 50(2):157-64. PubMed ID: 2311679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of 6-phosphogluconate dehydrogenase by carbamylation and protection by alpha-crystallin, a chaperone-like protein.
    Ganea E; Harding JJ
    Biochem Biophys Res Commun; 1996 May; 222(2):626-31. PubMed ID: 8670255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bendazac prevents cyanate binding to soluble lens proteins and cyanate-induced phase-separation opacities in vitro: a possible mechanism by which bendazac could delay cataract.
    Lewis BS; Rixon KC; Harding JJ
    Exp Eye Res; 1986 Dec; 43(6):973-9. PubMed ID: 3817034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonenzymatic glycosylation (glycation) of lens crystallins in diabetes and aging.
    Abraham EC; Swamy MS; Perry RE
    Prog Clin Biol Res; 1989; 304():123-39. PubMed ID: 2780679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates of carbamylation of specific lysyl residues in bovine alpha-crystallins.
    Qin W; Smith JB; Smith DL
    J Biol Chem; 1992 Dec; 267(36):26128-33. PubMed ID: 1464624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The non-enzymic glycosylation of bovine lens proteins by glucosamine and its inhibition by aspirin, ibuprofen and glutathione.
    Ajiboye R; Harding JJ
    Exp Eye Res; 1989 Jul; 49(1):31-41. PubMed ID: 2759189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonenzymatic modification of lens crystallins by prednisolone induces sulfhydryl oxidation and aggregate formation: in vitro and in vivo studies.
    Bucala R; Manabe S; Urban RC; Cerami A
    Exp Eye Res; 1985 Sep; 41(3):353-63. PubMed ID: 4065253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonenzymatic glycosylation of bovine lens crystallins. Effect of aging.
    Chiou SH; Chylack LT; Tung WH; Bunn HF
    J Biol Chem; 1981 May; 256(10):5176-80. PubMed ID: 7228874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-enzymatic glycosylation in human diabetic lens crystallins.
    Liang JN; Hershorin LL; Chylack LT
    Diabetologia; 1986 Apr; 29(4):225-8. PubMed ID: 3710014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-enzymic glycosylation (glycation) of lens proteins by galactose and protection by aspirin and reduced glutathione.
    Huby R; Harding JJ
    Exp Eye Res; 1988 Jul; 47(1):53-9. PubMed ID: 3409987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of aminoguanidine on the glycation (non-enzymic glycosylation) of lens proteins.
    Lewis BS; Harding JJ
    Exp Eye Res; 1990 May; 50(5):463-7. PubMed ID: 2373149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bendazac decreases in vitro glycation of human lens crystallins. Decrease of in vitro protein glycation by bendazac.
    Marques C; Ramalho JS; Pereira P; Mota MC
    Doc Ophthalmol; 1995; 90(4):395-404. PubMed ID: 8620822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased susceptibility to metal catalysed oxidation of diabetic lens beta L crystallin: possible protection by dietary supplementation with acetylsalicylic acid.
    Jones RH; Hothersall JS
    Exp Eye Res; 1993 Dec; 57(6):783-90. PubMed ID: 8150030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbamylation of human lens gamma-crystallins: relevance to cataract formation.
    Liu X; Li S
    Yan Ke Xue Bao; 1993 Sep; 9(3):136-42, 157. PubMed ID: 8168608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.